Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04044859 |
|---|---|
| Brief Title: | ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) |
| First Submitted : | July 3, 2019 |
| First Submitted that Met QC Criteria : | August 1, 2019 |
| First Posted : | August 5, 2019 |
| Last Update Submitted that Met QC Criteria : | February 15, 2024 |
| Last Update Posted : | February 16, 2024 |